Global Chronic Obstructive Pulmonary Disease Market Size, Status and Forecast 2024-2031

Report ID: 1013416 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Bronchodilators
        1.2.3 Glucocorticoids
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Chronic Obstructive Pulmonary Disease Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Prevention
        1.3.3 Diagnostic
        1.3.4 Treatment
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Chronic Obstructive Pulmonary Disease Market Perspective (2016-2027)
    2.2 Chronic Obstructive Pulmonary Disease Growth Trends by Regions
        2.2.1 Chronic Obstructive Pulmonary Disease Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Chronic Obstructive Pulmonary Disease Historic Market Share by Regions (2016-2021)
        2.2.3 Chronic Obstructive Pulmonary Disease Forecasted Market Size by Regions (2022-2027)
    2.3 Chronic Obstructive Pulmonary Disease Industry Dynamic
        2.3.1 Chronic Obstructive Pulmonary Disease Market Trends
        2.3.2 Chronic Obstructive Pulmonary Disease Market Drivers
        2.3.3 Chronic Obstructive Pulmonary Disease Market Challenges
        2.3.4 Chronic Obstructive Pulmonary Disease Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Chronic Obstructive Pulmonary Disease Players by Revenue
        3.1.1 Global Top Chronic Obstructive Pulmonary Disease Players by Revenue (2016-2021)
        3.1.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Players (2016-2021)
    3.2 Global Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disease Revenue
    3.4 Global Chronic Obstructive Pulmonary Disease Market Concentration Ratio
        3.4.1 Global Chronic Obstructive Pulmonary Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease Revenue in 2020
    3.5 Chronic Obstructive Pulmonary Disease Key Players Head office and Area Served
    3.6 Key Players Chronic Obstructive Pulmonary Disease Product Solution and Service
    3.7 Date of Enter into Chronic Obstructive Pulmonary Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disease Breakdown Data by Type
    4.1 Global Chronic Obstructive Pulmonary Disease Historic Market Size by Type (2016-2021)
    4.2 Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2022-2027)

5 Chronic Obstructive Pulmonary Disease Breakdown Data by Application
    5.1 Global Chronic Obstructive Pulmonary Disease Historic Market Size by Application (2016-2021)
    5.2 Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
    6.2 North America Chronic Obstructive Pulmonary Disease Market Size by Type
        6.2.1 North America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
        6.2.2 North America Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
        6.2.3 North America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
    6.3 North America Chronic Obstructive Pulmonary Disease Market Size by Application
        6.3.1 North America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
        6.3.2 North America Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
        6.3.3 North America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
    6.4 North America Chronic Obstructive Pulmonary Disease Market Size by Country
        6.4.1 North America Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021)
        6.4.2 North America Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
    7.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Type
        7.2.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
        7.2.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
        7.2.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
    7.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Application
        7.3.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
        7.3.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
        7.3.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
    7.4 Europe Chronic Obstructive Pulmonary Disease Market Size by Country
        7.4.1 Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021)
        7.4.2 Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
    8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type
        8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
    8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application
        8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
    8.4 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region
        8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
    9.2 Latin America Chronic Obstructive Pulmonary Disease Market Size by Type
        9.2.1 Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
        9.2.2 Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
        9.2.3 Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
    9.3 Latin America Chronic Obstructive Pulmonary Disease Market Size by Application
        9.3.1 Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
        9.3.2 Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
        9.3.3 Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
    9.4 Latin America Chronic Obstructive Pulmonary Disease Market Size by Country
        9.4.1 Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021)
        9.4.2 Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size (2016-2027)
    10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type
        10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2027)
    10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application
        10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2027)
    10.4 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country
        10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AstraZeneca
        11.1.1 AstraZeneca Company Details
        11.1.2 AstraZeneca Business Overview
        11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Introduction
        11.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.1.5 AstraZeneca Recent Development
    11.2 GSK
        11.2.1 GSK Company Details
        11.2.2 GSK Business Overview
        11.2.3 GSK Chronic Obstructive Pulmonary Disease Introduction
        11.2.4 GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.2.5 GSK Recent Development
    11.3 MSD
        11.3.1 MSD Company Details
        11.3.2 MSD Business Overview
        11.3.3 MSD Chronic Obstructive Pulmonary Disease Introduction
        11.3.4 MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.3.5 MSD Recent Development
    11.4 Sunovion
        11.4.1 Sunovion Company Details
        11.4.2 Sunovion Business Overview
        11.4.3 Sunovion Chronic Obstructive Pulmonary Disease Introduction
        11.4.4 Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.4.5 Sunovion Recent Development
    11.5 Novartis
        11.5.1 Novartis Company Details
        11.5.2 Novartis Business Overview
        11.5.3 Novartis Chronic Obstructive Pulmonary Disease Introduction
        11.5.4 Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.5.5 Novartis Recent Development
    11.6 Roche Group
        11.6.1 Roche Group Company Details
        11.6.2 Roche Group Business Overview
        11.6.3 Roche Group Chronic Obstructive Pulmonary Disease Introduction
        11.6.4 Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.6.5 Roche Group Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Chronic Obstructive Pulmonary Disease Introduction
        11.7.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.7.5 Pfizer Recent Development
    11.8 Jubilant Pharma Limited
        11.8.1 Jubilant Pharma Limited Company Details
        11.8.2 Jubilant Pharma Limited Business Overview
        11.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Introduction
        11.8.4 Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.8.5 Jubilant Pharma Limited Recent Development
    11.9 Almirall
        11.9.1 Almirall Company Details
        11.9.2 Almirall Business Overview
        11.9.3 Almirall Chronic Obstructive Pulmonary Disease Introduction
        11.9.4 Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.9.5 Almirall Recent Development
    11.10 Horizon Pharma
        11.10.1 Horizon Pharma Company Details
        11.10.2 Horizon Pharma Business Overview
        11.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Introduction
        11.10.4 Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.10.5 Horizon Pharma Recent Development
    11.11 Boehringer Ingelheim
        11.11.1 Boehringer Ingelheim Company Details
        11.11.2 Boehringer Ingelheim Business Overview
        11.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Introduction
        11.11.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021)
        11.11.5 Boehringer Ingelheim Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Bronchodilators
    Table 3. Key Players of Glucocorticoids
    Table 4. Key Players of Other
    Table 5. Global Chronic Obstructive Pulmonary Disease Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Chronic Obstructive Pulmonary Disease Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Chronic Obstructive Pulmonary Disease Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Chronic Obstructive Pulmonary Disease Market Share by Regions (2016-2021)
    Table 9. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Chronic Obstructive Pulmonary Disease Market Share by Regions (2022-2027)
    Table 11. Chronic Obstructive Pulmonary Disease Market Trends
    Table 12. Chronic Obstructive Pulmonary Disease Market Drivers
    Table 13. Chronic Obstructive Pulmonary Disease Market Challenges
    Table 14. Chronic Obstructive Pulmonary Disease Market Restraints
    Table 15. Global Chronic Obstructive Pulmonary Disease Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Chronic Obstructive Pulmonary Disease Market Share by Players (2016-2021)
    Table 17. Global Top Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease as of 2020)
    Table 18. Ranking of Global Top Chronic Obstructive Pulmonary Disease Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Chronic Obstructive Pulmonary Disease Product Solution and Service
    Table 22. Date of Enter into Chronic Obstructive Pulmonary Disease Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2016-2021)
    Table 26. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Chronic Obstructive Pulmonary Disease Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2016-2021)
    Table 30. Global Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. AstraZeneca Company Details
    Table 63. AstraZeneca Business Overview
    Table 64. AstraZeneca Chronic Obstructive Pulmonary Disease Product
    Table 65. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 66. AstraZeneca Recent Development
    Table 67. GSK Company Details
    Table 68. GSK Business Overview
    Table 69. GSK Chronic Obstructive Pulmonary Disease Product
    Table 70. GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 71. GSK Recent Development
    Table 72. MSD Company Details
    Table 73. MSD Business Overview
    Table 74. MSD Chronic Obstructive Pulmonary Disease Product
    Table 75. MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 76. MSD Recent Development
    Table 77. Sunovion Company Details
    Table 78. Sunovion Business Overview
    Table 79. Sunovion Chronic Obstructive Pulmonary Disease Product
    Table 80. Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 81. Sunovion Recent Development
    Table 82. Novartis Company Details
    Table 83. Novartis Business Overview
    Table 84. Novartis Chronic Obstructive Pulmonary Disease Product
    Table 85. Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 86. Novartis Recent Development
    Table 87. Roche Group Company Details
    Table 88. Roche Group Business Overview
    Table 89. Roche Group Chronic Obstructive Pulmonary Disease Product
    Table 90. Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 91. Roche Group Recent Development
    Table 92. Pfizer Company Details
    Table 93. Pfizer Business Overview
    Table 94. Pfizer Chronic Obstructive Pulmonary Disease Product
    Table 95. Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 96. Pfizer Recent Development
    Table 97. Jubilant Pharma Limited Company Details
    Table 98. Jubilant Pharma Limited Business Overview
    Table 99. Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 100. Jubilant Pharma Limited Recent Development
    Table 101. Almirall Company Details
    Table 102. Almirall Business Overview
    Table 103. Almirall Chronic Obstructive Pulmonary Disease Product
    Table 104. Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 105. Almirall Recent Development
    Table 106. Horizon Pharma Company Details
    Table 107. Horizon Pharma Business Overview
    Table 108. Horizon Pharma Chronic Obstructive Pulmonary Disease Product
    Table 109. Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 110. Horizon Pharma Recent Development
    Table 111. Boehringer Ingelheim Company Details
    Table 112. Boehringer Ingelheim Business Overview
    Table 113. Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product
    Table 114. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disease Business (2016-2021) & (US$ Million)
    Table 115. Boehringer Ingelheim Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Chronic Obstructive Pulmonary Disease Market Share by Type: 2020 VS 2027
    Figure 2. Bronchodilators Features
    Figure 3. Glucocorticoids Features
    Figure 4. Other Features
    Figure 5. Global Chronic Obstructive Pulmonary Disease Market Share by Application: 2020 VS 2027
    Figure 6. Prevention Case Studies
    Figure 7. Diagnostic Case Studies
    Figure 8. Treatment Case Studies
    Figure 9. Chronic Obstructive Pulmonary Disease Report Years Considered
    Figure 10. Global Chronic Obstructive Pulmonary Disease Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Chronic Obstructive Pulmonary Disease Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Chronic Obstructive Pulmonary Disease Market Share by Regions: 2020 VS 2027
    Figure 13. Global Chronic Obstructive Pulmonary Disease Market Share by Regions (2022-2027)
    Figure 14. Global Chronic Obstructive Pulmonary Disease Market Share by Players in 2020
    Figure 15. Global Top Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Obstructive Pulmonary Disease as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease Revenue in 2020
    Figure 17. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2016-2021)
    Figure 18. Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2022-2027)
    Figure 19. North America Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
    Figure 21. North America Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
    Figure 22. North America Chronic Obstructive Pulmonary Disease Market Share by Country (2016-2027)
    Figure 23. United States Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
    Figure 27. Europe Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
    Figure 28. Europe Chronic Obstructive Pulmonary Disease Market Share by Country (2016-2027)
    Figure 29. Germany Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Chronic Obstructive Pulmonary Disease Market Share by Region (2016-2027)
    Figure 39. China Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
    Figure 47. Latin America Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
    Figure 48. Latin America Chronic Obstructive Pulmonary Disease Market Share by Country (2016-2027)
    Figure 49. Mexico Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Chronic Obstructive Pulmonary Disease Market Share by Country (2016-2027)
    Figure 55. Turkey Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 59. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 60. MSD Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 61. Sunovion Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 62. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 63. Roche Group Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 64. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 65. Jubilant Pharma Limited Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 66. Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 67. Horizon Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 68. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall
Horizon Pharma
Boehringer Ingelheim
Frequently Asked Questions
Chronic Obstructive Pulmonary Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Chronic Obstructive Pulmonary Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Chronic Obstructive Pulmonary Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports